TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 5792611

Group type: EXPERIMENTAL
Intervention: Urinary concentrating ability assessment during 24 hours' deprivation of fluids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assessment of maximum urinary osmolality
Number of subjects: 0
Study: 30590973

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 50
Study: 29191188

Group type: EXPERIMENTAL
Intervention: Expectations scale
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 384
Study: 25638568

Group type: EXPERIMENTAL
Intervention: Piezoelectric corticotomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional orthodontic traction
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 22377778

Group type: EXPERIMENTAL
Intervention: simplified modified Rankin Scale questionnaire (smRSq)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: conventional modified Rankin Scale (mRS)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: comparison between mRS and smRSq
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: NIH Stroke Scale (NIHSS)
Number of subjects: 150
Study: 20357376

Group type: EXPERIMENTAL
Intervention: Automated telephone outreach with speech recognition (ATO-SR)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care (no intervention)
Number of subjects: 1200
Study: 18383334

Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 4.0 mg/ml) in girls
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 8.0 mg/ml) in nonatopic girls
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Methacholine challenge (PC20 < or = 2.0 mg/ml) in atopic boys
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Methacholine challenge in nonatopic boys
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Methacholine challenge in atopic girls
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Methacholine challenge in nonatopic girls
Number of subjects: 640
Study: 16027564

Group type: EXPERIMENTAL
Intervention: NDB-derived activities
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Matched to interest only activities
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched to skill level only treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 30
Study: 12453948

Group type: EXPERIMENTAL
Intervention: Glipizide GITS (maximum 20 mg)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Metformin (maximum 2,550 mg)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combination therapy (glipizide GITS + metformin)
Number of subjects: 91
Study: 10361626

Group type: EXPERIMENTAL
Intervention: Elcometrine
Number of subjects: 135

Group type: COMPARATOR
Intervention: Copper-T380 IUD
Number of subjects: 135
Study: 7556039

Group type: EXPERIMENTAL
Intervention: Exercise for 10 min
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exercise for 25 min
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exercise for 40 min
Number of subjects: 80

Group type: COMPARATOR
Intervention: Attention control for 10 min
Number of subjects: 80
Study: 2147787

Group type: EXPERIMENTAL
Intervention: Saliva stimulants (V6 chewing gum)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Saliva stimulants (Salivin lozenge)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All eight tested saliva stimulants and substitutes
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All eight products
Number of subjects: 106
Study: 6766269

Group type: EXPERIMENTAL
Intervention: Starr‐Edwards ball valve type 1200
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Starr‐Edwards ball valve type 2300
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Bjork‐Shiley disc valves
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Lillehei‐Kaster disc valves
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: All valve types
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Smaller ball valves
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Larger valves of all types
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Earlier valve replacement
Number of subjects: 449
Study: 29715369

Group type: EXPERIMENTAL
Intervention: PEG/PG QID (four times daily)
Number of subjects: 97

Group type: COMPARATOR
Intervention: PEG/PG PRN (as-needed)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: PEG/PG QID
Number of subjects: 97

Group type: COMPARATOR
Intervention: PEG/PG PRN
Number of subjects: 97
Study: 27389475

Group type: EXPERIMENTAL
Intervention: Cetuximab and radiotherapy (CRT)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 168
Study: 24556308

Group type: EXPERIMENTAL
Intervention: Contrast staining on CT after DSA
Number of subjects: 67

Group type: COMPARATOR
Intervention: No contrast staining on CT after DSA
Number of subjects: 67
Study: 22210721

Group type: EXPERIMENTAL
Intervention: Nasolabial flap (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Island flap (group B)
Number of subjects: 60
Study: 20384673

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g/day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 7.5 mg/week
Number of subjects: 38
Study: 18669515

Group type: EXPERIMENTAL
Intervention: Hysterical personality traits (object-dependence/ambivalence, egoism)
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Emotional suppression traits (unfulfilled needs for acceptance, altruism, rationalizing conflicts/frustrations)
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Loss-hopelessness traits (low sense of control, object-dependence/loss, object-dependence/happiness)
Number of subjects: 1306
Study: 15670536

Group type: EXPERIMENTAL
Intervention: Ranolazine 400 mg three times daily
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg/day
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 12055816

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anti-TB therapy alone
Number of subjects: 0
Study: 10490151

Group type: EXPERIMENTAL
Intervention: Regional Anesthesia and Analgesia (RAA) program
Number of subjects: 100
Study: 7589641

Group type: EXPERIMENTAL
Intervention: 1 mg-2.5 mg E2-nomegestrol acetate combination
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 1.5 mg-3.75 mg E2-nomegestrol acetate combination
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 1883123

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6751176

Group type: EXPERIMENTAL
Intervention: 5 mg terbutaline
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 20 mg metaproterenol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31277446

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with 2-3 weekly servings of fresh, lean pork (MedPork)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low-fat (LF) control diet
Number of subjects: 35
Study: 28893187

Group type: EXPERIMENTAL
Intervention: Dual task (DT) managing balance training, 12 sessions, 60 min each, over 12 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (non-training)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Dual task (DT) managing balance training
Number of subjects: 95
Study: 26631210

Group type: EXPERIMENTAL
Intervention: Platform system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (stem removal)
Number of subjects: 0
Study: 26055445

Group type: EXPERIMENTAL
Intervention: Emotion and Motivation Self‐regulation Questionnaire (EMSR‐Q)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Self-regulation styles as predictors
Number of subjects: 664
Study: 22415333

Group type: EXPERIMENTAL
Intervention: Famotidine treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 19714267

Group type: EXPERIMENTAL
Intervention: Virtual Reality Immersion (VRI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Audiovisual Distraction (AVD)
Number of subjects: 24
Study: 17724493

Group type: EXPERIMENTAL
Intervention: Energy-adjusted lutein and zeaxanthin intake
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Energy-adjusted omega-3 fatty acid intake (modelled as a quintile median)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Total fat and other fat subgroups (saturated, polyunsaturated, monounsaturated, trans fatty acids, omega-6 fatty acids)
Number of subjects: 254
Study: 16015596

Group type: EXPERIMENTAL
Intervention: GnRH-DT vaccine administered intramuscularly on weeks 1, 3, and 7
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Docetaxel infused intravenously on day 1 of weeks 1, 4, 7, and 10
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Concurrent treatment with docetaxel and GnRH-DT vaccine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Docetaxel with high-dose dexamethasone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GnRH-DT vaccine
Number of subjects: 12
Study: 11835120

Group type: EXPERIMENTAL
Intervention: Technosphere/Insulin (TI) via inhalation
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intravenous regular human insulin (HI)
Number of subjects: 5
Study: 10049414

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice daily) and Rowachol (2 tablets 3 times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No drug treatment (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and Rowachol
Number of subjects: 20
Study: 7586262

Group type: EXPERIMENTAL
Intervention: Steroid-eluting lead (Medtronic model 4068)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control lead (Medtronic model 4058)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both leads
Number of subjects: 0
Study: 2338106

Group type: EXPERIMENTAL
Intervention: Chemotherapy without any antiemetic treatment
Number of subjects: 849

Group type: COMPARATOR
Intervention: Visual analogue scale (VAS)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Discrete scale (DS)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Continuous chromatic analogue scale (ACCS)
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Nausea dimensions (Q, E, MI)
Number of subjects: 849
Study: 111546

Group type: EXPERIMENTAL
Intervention: Lactinex (Lactobacillus acidophilus and L bulgaricus), 1 packet four times daily for the first five days of ampicillin therapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo, 1 packet four times daily for the first five days of ampicillin therapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Lactinex (Lactobacillus acidophilus and L bulgaricus)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 30173369

Group type: EXPERIMENTAL
Intervention: Multifaceted workplace intervention (participatory ergonomics, physical training, cognitive-behavioral training)
Number of subjects: 420
Study: 28665468

Group type: EXPERIMENTAL
Intervention: Right arm peripherally inserted central catheters (PICCs)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Left arm peripherally inserted central catheters (PICCs)
Number of subjects: 202
Study: 26076180

Group type: EXPERIMENTAL
Intervention: 3D high-definition imaging system
Number of subjects: 80

Group type: COMPARATOR
Intervention: 2D high-definition imaging system
Number of subjects: 80
Study: 24131736

Group type: EXPERIMENTAL
Intervention: PF-04360365 (0.1, 0.5, 1, 5, or 10 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21288598

Group type: EXPERIMENTAL
Intervention: Deferasirox (20 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 19850703

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart twice daily
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Prandial insulin aspart three times daily
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Basal insulin detemir once daily (twice if required)
Number of subjects: 708
Study: 18020110

Group type: COMPARATOR
Intervention: Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 0

Group type: COMPARATOR
Intervention: N-methyl-D-aspartate receptor antagonist (memantine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disease-modifying treatments
Number of subjects: 0
Study: 14678954

Group type: EXPERIMENTAL
Intervention: Gastric inhibitory polypeptide (GIP) infusion (2 pmol.kg(‐1).min(‐1))
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GIP infusion
Number of subjects: 15
Study: 11434175

Group type: EXPERIMENTAL
Intervention: High neuroticism group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Low neuroticism group
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Neurotic boys
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Neurotic girls
Number of subjects: 121
Study: 9892909

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 microg/g)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Betamethasone dipropionate (64 mg/g) and salicylic acid (0.03 g/g) ointment
Number of subjects: 58
Study: 8070028

Group type: EXPERIMENTAL
Intervention: Etoposide phosphate (EP) given at maximum tolerated doses of 100 mg/m2 (daily for 5 days) and 150 mg/m2 (on days 1, 3, and 5)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide phosphate (EP)
Number of subjects: 0
Study: 3054047

Group type: EXPERIMENTAL
Intervention: Chlorhexidine delivered into periodontal pockets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole delivered into periodontal pockets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetracycline delivered into periodontal pockets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated sites
Number of subjects: 0
Study: 30020092

Group type: EXPERIMENTAL
Intervention: Video-based games (Xbox 360 Kinect) for 3 days/week for 8 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Activities of daily living practiced using real materials
Number of subjects: 62
Study: 28854725

Group type: EXPERIMENTAL
Intervention: Registered trials
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Prospectively registered trials
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Trials registered within 6 months of first patient enrolment
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Retrospectively registered trials
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Prospective trial registration by country
Number of subjects: 693
Study: 25682703

Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention for children
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 95
Study: 23701860

Group type: EXPERIMENTAL
Intervention: LATERAL board
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: FREEMAN board
Number of subjects: 13

Group type: COMPARATOR
Intervention: JAKOBS(®) board
Number of subjects: 13

Group type: COMPARATOR
Intervention: FLAT surface
Number of subjects: 13
Study: 20951617

Group type: EXPERIMENTAL
Intervention: Group instructed that pain perception over time will habituate (n=10)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Group instructed that pain will increase (n=9)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Group instructed that pain will remain stable (n=8)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 37
Study: 18559367

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 660

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Amoxicillin (HIV infected)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Placebo (HIV infected)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Amoxicillin (HIV uninfected)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Placebo (HIV uninfected)
Number of subjects: 660
Study: 16861079

Group type: EXPERIMENTAL
Intervention: Self-etching-adhesive-modified EndoRez technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: EndoRez alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil Liner Bond 2V/EndoRez
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NaOCl-1 h/EDTA-2min/Clearfil Liner Bond 2V/EndoRez
Number of subjects: 0
Study: 14713092

Group type: EXPERIMENTAL
Intervention: 3-D ultrasound (3-DUS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 9
Study: 10844161

Group type: EXPERIMENTAL
Intervention: Pycnogenol (French maritime pine bark extract), 100 mg x 3/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9070128

Group type: EXPERIMENTAL
Intervention: Cytotoxic drug delivery system using 5-fluorouracil applied directly to the cervix.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract).
Number of subjects: 104
Study: 8508727

Group type: EXPERIMENTAL
Intervention: Alcohol Cue
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Neutral Cues)
Number of subjects: 30
Study: 2878839

Group type: EXPERIMENTAL
Intervention: Triacetin-prostaglandin E2-gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-treated group)
Number of subjects: 0
Study: 29140138

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg b.i.d.)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Celecoxib and COX-2 expression
Number of subjects: 316
Study: 27034127

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT)
Number of subjects: 58100

Group type: COMPARATOR
Intervention: Standard warm-up
Number of subjects: 58100
Study: 26100406

Group type: EXPERIMENTAL
Intervention: Next-generation sequencing (NGS)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Array comparative genomic hybridization (aCGH)
Number of subjects: 172
Study: 24000376

Group type: EXPERIMENTAL
Intervention: Predictive biomarker stratified design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instrumental variable (IV) regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stratification and treatment-effect mediation
Number of subjects: 0
Study: 21114808

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) intervention
Number of subjects: 5023

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 5023

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 5023
Study: 17638034

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment plus routine care
Number of subjects: 489

Group type: COMPARATOR
Intervention: Routine care alone
Number of subjects: 489
Study: 16842664

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) in CAD group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (normal coronary angiogram), n = 82
Number of subjects: 120
Study: 12933772

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 2562

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2562

Group type: COMPARATOR
Intervention: Intervention group vs Control group
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: One year after the intervention
Number of subjects: 2562
Study: 11027812

Group type: EXPERIMENTAL
Intervention: NYVAC-JEV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ALVAC-JEV
Number of subjects: 20

Group type: COMPARATOR
Intervention: Formalin-inactivated JE and placebo vaccines
Number of subjects: 20
Study: 8826492

Group type: EXPERIMENTAL
Intervention: Oswestry Questionnaire
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Roland Disability Questionnaire
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Severity of the main complaint
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Visual analog scale for pain
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Effect size statistics
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Receiver-operating characteristic curves
Number of subjects: 81
Study: 1418912

Group type: EXPERIMENTAL
Intervention: Harmonized treatment protocols for all types of acute leukaemias in childhood since January 1992.
Number of subjects: 2000
Study: 6488684

Group type: EXPERIMENTAL
Intervention: Tiamidine (TIAM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clonidine (CLON)
Number of subjects: 30
Study: 30570525

Group type: EXPERIMENTAL
Intervention: Immediate initiation of ART after home-based testing
Number of subjects: 777

Group type: COMPARATOR
Intervention: Control group following national guidelines for ART initiation
Number of subjects: 777
Study: 28130967

Group type: EXPERIMENTAL
Intervention: Surfactant administration by laryngeal mask airway (LMA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Surfactant administration by endotracheal tube (ETT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: LMA group
Number of subjects: 48

Group type: COMPARATOR
Intervention: LMA group and ETT group
Number of subjects: 48
Study: 25976090

Group type: EXPERIMENTAL
Intervention: Healing Touch (noninvasive energy therapy) for 15 minutes prior to biopsy procedure
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 73
Study: 25124490

Group type: EXPERIMENTAL
Intervention: Oligonol 200 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22076964

Group type: EXPERIMENTAL
Intervention: fMRI measurement of retrieval-related hippocampal activity
Number of subjects: 0
Study: 19079142

Group type: EXPERIMENTAL
Intervention: 360 degree anterior capsule polishing (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No anterior capsule polishing (group 2, controls)
Number of subjects: 60
Study: 17347283

Group type: EXPERIMENTAL
Intervention: Mixed HDF
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mid-dilution HDF
Number of subjects: 10
Study: 15893381

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (MgSO(4)) administered at 150-200 mg/h for 24 hours (n=22)
Number of subjects: 41

Group type: COMPARATOR
Intervention: NaCl 0.9% administered intravenously (n=19)
Number of subjects: 41
Study: 16735185

Group type: EXPERIMENTAL
Intervention: NMS60 (0.1 or 0.2 mmol (Gd)/kg)
Number of subjects: 10